Abstinence Orientation and Treatment Practice: An Analysis of German Settings Providing Opioid Maintenance Therapy

REFERENCES

• Amato, L., Davoli, M., Perucci, C. A., Ferri, M., Faggiano, F., & Mattick, P. R. (2005). An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research. Journal of Substance Abuse Treatment, 28(4), 321–329.
   PubMed Web of Science ®Google Scholar
• Bell, J., Chan, J., & Kuk, A. (1995). Investigating the influence of treatment philosophy on outcome of methadone maintenance. Addiction (Abingdon, England), 90(6), 823–830.
   PubMed Web of Science ®Google Scholar
• Betäubungsmittelverschreibeverordnung, BtMVV. As amended on July 15, 2009.
   Google Scholar
• Brady, T. M., Salvucci, S., Sverdlov, L. S., Male, A., Kyeyune, H., Sikali, E., (2005). Methadone dosage and retention: An examination of the 60 mg/day threshold. Journal of Addictive Diseases, 24(3), 23–47.
   PubMed Web of Science ®Google Scholar
• Caplehorn, J. R. (1994). A comparison of abstinence-oriented and indefinite methadone maintenance treatment. International Journal of the Addictions, 29(11), 1361–1375.
   PubMedGoogle Scholar
• Caplehorn, J. R., Hartel, D. M., & Irwig, L. (1997). Measuring and comparing the attitudes and beliefs of staff working in New York methadone maintenance clinics. Substance Use and Misuse, 32(4), 399–413.
   PubMed Web of Science ®Google Scholar
• Caplehorn, J. R., Irwig, L., & Saunders, J. B. (1996a). Attitudes and beliefs of staff working in methadone maintenance clinics. Substance Use and Misuse, 31(4), 437–452.
   PubMed Web of Science ®Google Scholar
• Caplehorn, J. R., Irwig, L., & Saunders, J. B. (1996b). Physicians’ attitudes and retention of patients in their methadone maintenance programs. Substance Use and Misuse, 31(6), 663–677.
   PubMed Web of Science ®Google Scholar
• Caplehorn, J. R., Lumley, T. S., & Irwig, L. (1998). Staff attitudes and retention of patients in methadone maintenance programs. Drug and Alcohol Dependence, 52(1), 57–61.
   PubMed Web of Science ®Google Scholar
• Caplehorn, J. R., McNeil, D. R., & Kleinbaum, D. G. (1993). Clinic policy and retention in methadone maintenance. International Journal of the Addictions, 28(1), 73–89.
   PubMed Web of Science ®Google Scholar
• Clausen, T., Anchersen, K., & Waal, H. (2007). Mortality prior to, during and after opioid maintenance treatment (OMT): A national prospective cross-registry study. Drug and Alcohol Dependence, 94, 151–157
   PubMed Web of Science ®Google Scholar
• Connock, M., Juarez-Garcia, A., Jowett, S., Frew, E., Liu, Z., Taylor, R. J., (2007). Methadone and buprenorphine for the management of opioid dependence: A systematic review and economic evaluation. Health Technology Assessment (Winchester, England), 11(9), 1–171.
   PubMed Web of Science ®Google Scholar
• Cushman, P. (1978). Abstinence following detoxification and methadone-maintenance treatment. American Journal of Medicine, 65(1), 46–52.
   PubMed Web of Science ®Google Scholar
• D'Aunno, T., & Pollack, H. A. (2002). Changes in methadone treatment practices: Results from a national panel study, 1988–2000. Journal of the American Medical Association, 288(7), 850–856.
   PubMed Web of Science ®Google Scholar
• D'Aunno, T., & Vaughn, T. E. (1992). Variations in methadone treatment practices. Results from a national study. Journal of the American Medical Association, 267(2), 253–258.
   PubMed Web of Science ®Google Scholar
• Faggiano, F., Vigna-Taglianti, F., Versino, E., & Lemma, P. (2003). Methadone maintenance at different dosages for opioid dependence. Cochrane Database of Systematic Reviews, 3, CD002208.
   PubMedGoogle Scholar
• Gerlach, R., & Caplehorn, J. R. (1999). Attitudes and beliefs of doctors prescribing methadone to addicts in the Westfalen-Lippe region of Germany. Drug and Alcohol Review, 18, 163–170.
   Web of Science ®Google Scholar
• Gerlach, R., & Stöver, H. (2007). Begleitende psychosoziale Unterstützung in der Substitutionsbehandlung [Accompanying psychosocial interventions in opiate agonist treatment]. In E. Beubler, E. Haltmayer, & H. Springer (Hrsg.), Opiatabhängigkeit [Opiate dependence] (2. Aufl., S. 225–230). Berlin/New York: Springer.
   Google Scholar
• Gjersing, L., Waal, H., Caplehorn, J. R., Gossop, M., & Clausen, T. (2010). Staff attitudes and the associations with treatment organisation, clinical practices and outcomes in opioid maintenance treatment. BMC Health Services Research, 10(1), 194.
   PubMedGoogle Scholar
• Gossop, M., Marsden, J., Stewart, D., & Treacy, S. (2001). Outcomes after methadone maintenance and methadone reduction treatments: Two-year follow-up results from the National Treatment Outcome Research Study. Drug and Alcohol Dependence, 62(3), 255–264.
   PubMed Web of Science ®Google Scholar
• Johansson, B. A., Berglund, M., & Lindgren, A. (2007). Efficacy of maintenance treatment with methadone for opioid dependence: A meta-analytical study. Nordic Journal of Psychiatry, 61(4), 288–295.
   PubMed Web of Science ®Google Scholar
• Joseph, H., Stancliff, S., & Langrod, J. (2000). Methadone maintenance treatment (MMT): A review of historical and clinical issues. Mount Sinai Journal of Medicine, 67(5–6), 347–364.
   PubMed Web of Science ®Google Scholar
• Lind, B., Chen, S., Weatherburn, D., & Mattick, R. (2005). The effectiveness of methadone maintenance treatment in controlling crime: An Australian aggregate-level analysis. British Journal of Criminology, 45(2), 201–211.
   Web of Science ®Google Scholar
• Maremmani, I., Pani, P. P., Pacini, M., & Perugi, G. (2007). Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients. Journal of Substance Abuse Treatment, 33(1), 91–98.
   PubMed Web of Science ®Google Scholar
• Maxwell, S., & Shinderman, M. S. (2002). Optimizing long-term response to methadone maintenance treatment: A 152-week follow-up using higher-dose methadone. Journal of Addictive Diseases, 21(3), 1–12.
   PubMed Web of Science ®Google Scholar
• Perkins, M., & Bloch, H. (1971). Some failures in methadone treatment. American Journal of Psychiatry, 128(1), 47–51.
   PubMed Web of Science ®Google Scholar
• Scherbaum, N., Specka, M., Hauptmann, G., & Gastpar, M. (2002). Senkt die Methadonsubstitutionsbehandlung die Mortalität Opiatabhängiger? Fortschritte der Neurologie Psychiatrie, 70, 455–461.
   PubMedGoogle Scholar
• Soyka, M., Apelt, S. M., Lieb, M., & Wittchen, H.-U. (2006). One-year mortality rates of patients receiving methadone and buprenorphine maintenance therapy: A Nationally Representative Cohort Study in 2694 patients. Journal of Clinical Psychopharmacology, 26(6), 657–660.
   PubMed Web of Science ®Google Scholar
• Willenbring, M., Hagedorn, H., Postier, A., & Kenny, M. (2004). Variations in evidence-based clinical practices in nine United States Veterans administration opioid agonist therapy clinics. Drug and Alcohol Dependence, 75(1), 97–106.
   PubMed Web of Science ®Google Scholar
• Wittchen, H.-U., Apelt, S. M., Soyka, M., Gastpar, M., Backmund, M., Gölz, J., (2008). Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: A naturalistic study in 2694 patients. Drug and Alcohol Dependence, 95(3), 145–157.
   Web of Science ®Google Scholar